310 related articles for article (PubMed ID: 18378121)
1. Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia.
Madeira C; Freitas ME; Vargas-Lopes C; Wolosker H; Panizzutti R
Schizophr Res; 2008 Apr; 101(1-3):76-83. PubMed ID: 18378121
[TBL] [Abstract][Full Text] [Related]
2. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.
Chumakov I; Blumenfeld M; Guerassimenko O; Cavarec L; Palicio M; Abderrahim H; Bougueleret L; Barry C; Tanaka H; La Rosa P; Puech A; Tahri N; Cohen-Akenine A; Delabrosse S; Lissarrague S; Picard FP; Maurice K; Essioux L; Millasseau P; Grel P; Debailleul V; Simon AM; Caterina D; Dufaure I; Malekzadeh K; Belova M; Luan JJ; Bouillot M; Sambucy JL; Primas G; Saumier M; Boubkiri N; Martin-Saumier S; Nasroune M; Peixoto H; Delaye A; Pinchot V; Bastucci M; Guillou S; Chevillon M; Sainz-Fuertes R; Meguenni S; Aurich-Costa J; Cherif D; Gimalac A; Van Duijn C; Gauvreau D; Ouellette G; Fortier I; Raelson J; Sherbatich T; Riazanskaia N; Rogaev E; Raeymaekers P; Aerssens J; Konings F; Luyten W; Macciardi F; Sham PC; Straub RE; Weinberger DR; Cohen N; Cohen D
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13675-80. PubMed ID: 12364586
[TBL] [Abstract][Full Text] [Related]
3. Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain.
Strick CA; Li C; Scott L; Harvey B; Hajós M; Steyn SJ; Piotrowski MA; James LC; Downs JT; Rago B; Becker SL; El-Kattan A; Xu Y; Ganong AH; Tingley FD; Ramirez AD; Seymour PA; Guanowsky V; Majchrzak MJ; Fox CB; Schmidt CJ; Duplantier AJ
Neuropharmacology; 2011; 61(5-6):1001-15. PubMed ID: 21763704
[TBL] [Abstract][Full Text] [Related]
4. Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.
Williams M
Biochem Pharmacol; 2009 Dec; 78(11):1360-5. PubMed ID: 19591808
[TBL] [Abstract][Full Text] [Related]
5. The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
Smith SM; Uslaner JM; Yao L; Mullins CM; Surles NO; Huszar SL; McNaughton CH; Pascarella DM; Kandebo M; Hinchliffe RM; Sparey T; Brandon NJ; Jones B; Venkatraman S; Young MB; Sachs N; Jacobson MA; Hutson PH
J Pharmacol Exp Ther; 2009 Mar; 328(3):921-30. PubMed ID: 19088300
[TBL] [Abstract][Full Text] [Related]
6. Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.
Frattini LF; Piubelli L; Sacchi S; Molla G; Pollegioni L
FEBS J; 2011 Nov; 278(22):4362-73. PubMed ID: 21981077
[TBL] [Abstract][Full Text] [Related]
7. Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.
Sershen H; Hashim A; Dunlop DS; Suckow RF; Cooper TB; Javitt DC
Neurochem Res; 2016 Feb; 41(1-2):398-408. PubMed ID: 26857796
[TBL] [Abstract][Full Text] [Related]
8. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder.
Schumacher J; Jamra RA; Freudenberg J; Becker T; Ohlraun S; Otte AC; Tullius M; Kovalenko S; Bogaert AV; Maier W; Rietschel M; Propping P; Nöthen MM; Cichon S
Mol Psychiatry; 2004 Feb; 9(2):203-7. PubMed ID: 14966479
[TBL] [Abstract][Full Text] [Related]
9. No association of G72 and D-amino acid oxidase genes with schizophrenia.
Liu YL; Fann CS; Liu CM; Chang CC; Wu JY; Hung SI; Liu SK; Hsieh MH; Hwang TJ; Chan HY; Chen JJ; Faraone SV; Tsuang MT; Chen WJ; Hwu HG
Schizophr Res; 2006 Oct; 87(1-3):15-20. PubMed ID: 16842973
[TBL] [Abstract][Full Text] [Related]
10. Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies.
Szilágyi B; Ferenczy GG; Keserű GM
Expert Opin Drug Discov; 2018 Oct; 13(10):973-982. PubMed ID: 30220232
[TBL] [Abstract][Full Text] [Related]
11. Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1).
Kapoor R; Lim KS; Cheng A; Garrick T; Kapoor V
Brain Res; 2006 Aug; 1106(1):205-210. PubMed ID: 16828464
[TBL] [Abstract][Full Text] [Related]
12. D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy.
Sacchi S; Rosini E; Pollegioni L; Molla G
Curr Pharm Des; 2013; 19(14):2499-511. PubMed ID: 23116391
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia.
Ferraris DV; Tsukamoto T
Curr Pharm Des; 2011; 17(2):103-11. PubMed ID: 21361869
[TBL] [Abstract][Full Text] [Related]
14. Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia.
Boks MP; Rietkerk T; van de Beek MH; Sommer IE; de Koning TJ; Kahn RS
Eur Neuropsychopharmacol; 2007 Sep; 17(9):567-72. PubMed ID: 17250995
[TBL] [Abstract][Full Text] [Related]
15. d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia.
Verrall L; Walker M; Rawlings N; Benzel I; Kew JN; Harrison PJ; Burnet PW
Eur J Neurosci; 2007 Sep; 26(6):1657-69. PubMed ID: 17880399
[TBL] [Abstract][Full Text] [Related]
16. Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study.
Habl G; Zink M; Petroianu G; Bauer M; Schneider-Axmann T; von Wilmsdorff M; Falkai P; Henn FA; Schmitt A
J Neural Transm (Vienna); 2009 Dec; 116(12):1657-65. PubMed ID: 19823762
[TBL] [Abstract][Full Text] [Related]
17. A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia.
Bendikov I; Nadri C; Amar S; Panizzutti R; De Miranda J; Wolosker H; Agam G
Schizophr Res; 2007 Feb; 90(1-3):41-51. PubMed ID: 17156977
[TBL] [Abstract][Full Text] [Related]
18. Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia.
Shinkai T; De Luca V; Hwang R; Müller DJ; Lanktree M; Zai G; Shaikh S; Wong G; Sicard T; Potapova N; Trakalo J; King N; Matsumoto C; Hori H; Wong AH; Ohmori O; Macciardi F; Nakamura J; Kennedy JL
Neuromolecular Med; 2007; 9(2):169-77. PubMed ID: 17627036
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human D-amino acid oxidase.
Molla G; Sacchi S; Bernasconi M; Pilone MS; Fukui K; Polegioni L
FEBS Lett; 2006 Apr; 580(9):2358-64. PubMed ID: 16616139
[TBL] [Abstract][Full Text] [Related]
20. Factors regulating serine racemase and d-amino acid oxidase expression in the mouse striatum.
Takagi S; Balu DT; Coyle JT
Brain Res; 2021 Jan; 1751():147202. PubMed ID: 33171153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
